Cardiac ischemia refers to a condition where the blood flow to the heart muscle is reduced or restricted, often due to the narrowing or blockage of coronary arteries. This insufficient blood supply deprives the heart muscle of essential oxygen and nutrients, leading to potential damage or even death of the affected tissue. Cardiac ischemia is a critical component in the development of various heart-related issues, such as angina and myocardial infarction (heart attack). Common symptoms include chest pain or discomfort, shortness of breath, and fatigue. Timely diagnosis and intervention are crucial in managing cardiac ischemia to prevent more severe complications and improve overall heart health. Lifestyle changes, medications, and in some cases, medical procedures may be employed to address and mitigate the effects of cardiac ischemia. Regular monitoring and collaboration with healthcare professionals are key in managing this condition effectively.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India